Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

ETHYL LOFLAZEPATE vs ETODOLAC: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

ETHYL LOFLAZEPATE vs ETODOLAC: Safety Overview

Metric ETHYL LOFLAZEPATE ETODOLAC
Total FAERS Reports 215 681
Deaths Reported 16 70
Death Rate 7.4% 10.3%
Hospitalizations 98 192
Average Patient Age 51.5 yrs 59.1 yrs
% Female Patients 39.7% 68.7%
FDA Approval Date N/A Apr 11, 1997
Manufacturer N/A Preferred Pharmaceuticals Inc.
Route N/A ORAL
Marketing Status N/A Discontinued